Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 622,710 |
|
|||||
| News | - | ||||||
| Day High | 1.51 | Low High |
|||||
| Day Low | 1.44 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| SELLAS Life Sciences Group Inc | SLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.04 | -2.70% | 1.44 | 19:22:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.49 | 1.44 | 1.51 | 1.47 | 1.48 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,776 | 622,710 | $ 1.47 | $ 916,302 | - | 0.4986 - 1.914 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:54 | 4 | $ 1.48 | USD |
SELLAS Life Sciences Group Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 47.13M | 32.06M | - | 0 | -37.34M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SELLAS Life Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.34 | 1.51 | 1.34 | 1.43 | 520,618 | 0.10 | 7.46% |
| 1 Month | 1.285 | 1.54 | 1.26 | 1.41 | 740,037 | 0.155 | 12.06% |
| 3 Months | 1.62 | 1.72 | 0.96 | 1.29 | 1,491,279 | -0.18 | -11.11% |
| 6 Months | 1.08 | 1.72 | 0.4986 | 1.07 | 1,267,793 | 0.36 | 33.33% |
| 1 Year | 1.75 | 1.914 | 0.4986 | 1.10 | 820,804 | -0.31 | -17.71% |
| 3 Years | 10.65 | 15.0789 | 0.4986 | 2.76 | 459,023 | -9.21 | -86.48% |
| 5 Years | 0.5374 | 19.38 | 0.11 | 1.97 | 2,414,648 | 0.9026 | 167.96% |
SELLAS Life Sciences Description
| SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. |
